Deka Bank Deutsche Girozentrale Ironwood Pharmaceuticals Inc Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 04, 2020	SELL	$9.14 - $11.97 $1.23 Million - $1.61 Million	-134,500 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$8.58 - $14.01 $247,104 - $403,488	-28,800 Reduced 17.64%	134,500 $1.38 Million
Q2 2019 Aug 01, 2019	BUY	$9.8 - $12.89 $1.38 Million - $1.81 Million	140,343 Added 611.33%	163,300 $1.76 Million
Q1 2019 May 10, 2019	SELL	$8.27 - $12.73 $550,533 - $847,436	-66,570 Reduced 74.36%	22,957 $440,000
Q4 2018 Feb 12, 2019	BUY	$7.8 - $16.13 $519,246 - $1.07 Million	66,570 Added 289.98%	89,527 $879,000
Q3 2018 Nov 09, 2018	BUY	$14.31 - $17.65 $44,461 - $54,838	3,107 Added 15.65%	22,957 $0
Q2 2018 Aug 14, 2018	SELL	$11.83 - $16.2 $473,200 - $648,000	-40,000 Reduced 66.83%	19,850 $376,000
Q1 2018 May 03, 2018	BUY	$11.13 - $13.63 $10,573 - $12,948	950 Added 1.61%	59,850 $910,000
Q3 2017 Nov 06, 2017	BUY	$12.07 - $14.87 $710,923 - $875,843	58,900	58,900 $879,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.